Department of Biochemistry, Medical Faculty, Justus Liebig University, German Center for Lung Research Giessen, Germany.
Front Oncol. 2012 Dec 31;2:204. doi: 10.3389/fonc.2012.00204. eCollection 2012.
Post-translational modifications (PTMs) regulate multiple biological functions of the promyelocytic leukemia (PML) protein and also the fission, disassembly, and rebuilding of PML nuclear bodies (PML-NBs) during the cell cycle. Pathway-specific PML modification patterns ensure proper signal output from PML-NBs that suit the specific functional requirements. Here we comprehensively review the signaling pathways and enzymes that modify PML and also the oncogenic PML-RARα fusion protein. Many PTMs occur in a hierarchical and timely organized fashion. Phosphorylation or acetylation constitutes typical starting points for many PML modifying events, while degradative ubiquitination is an irreversible end point of the modification cascade. As this hierarchical organization of PTMs frequently turns phosphorylation events as primordial events, kinases or phosphatases regulating PML phosphorylation may be interesting drug targets to manipulate the downstream modifications and thus the stability and function of PML or PML-RARα.
翻译后修饰(PTMs)调节早幼粒细胞白血病(PML)蛋白的多种生物学功能,也调节细胞周期中PML核体(PML-NBs)的分裂、解体和重建。特定途径的PML修饰模式可确保PML-NBs产生适合特定功能需求的适当信号输出。在此,我们全面综述了修饰PML以及致癌性PML-RARα融合蛋白的信号通路和酶。许多翻译后修饰以分级且适时组织的方式发生。磷酸化或乙酰化构成许多PML修饰事件的典型起始点,而降解性泛素化是修饰级联反应的不可逆终点。由于这种翻译后修饰的分级组织经常将磷酸化事件作为原始事件,调节PML磷酸化的激酶或磷酸酶可能是操纵下游修饰从而影响PML或PML-RARα稳定性和功能的有趣药物靶点。